TXNIP and early-onset autosomal dominant Alzheimer disease: Particular consideration will be on how TXNIP and the TRX system may be involved in the pathological features of Alzheimer’s disease (AD), a chronic neurodegenerative disease of elderly people, which have been associated with abnormalities in cellular glucose metabolism, mitochondrial dysfunction, inflammation, and oxidative stress, among others [25].